30 related articles for article (PubMed ID: 38627251)
1. Investigating the anti-growth, anti-resistance, and anti-virulence activities of
Uc-Cachón AH; Dzul-Beh A; González-Cortázar M; Zamilpa-Álvarez A; Molina-Salinas GM
Heliyon; 2024 May; 10(10):e31420. PubMed ID: 38813144
[No Abstract] [Full Text] [Related]
2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
3. Adaptations of carbapenem resistant
Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
[No Abstract] [Full Text] [Related]
4. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
[TBL] [Abstract][Full Text] [Related]
5. Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii.
Thadtapong N; Chaturongakul S; Napaswad C; Dubbs P; Soodvilai S
Sci Rep; 2024 Apr; 14(1):9863. PubMed ID: 38684853
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
Alharbe R; Almansour A; Kwon DH
Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060
[TBL] [Abstract][Full Text] [Related]
7. Dihydrophenazine: a multifunctional new weapon that kills multidrug-resistant Acinetobacter baumannii and restores carbapenem and oxidative stress susceptibilities.
Mahdally NH; ElShiekh RA; Thissera B; Eltaher A; Osama A; Mokhtar M; Elhosseiny NM; Kashef MT; Magdeldin S; El Halawany AM; Rateb ME; Attia AS
J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38627251
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Ibrahim ME
Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):1. PubMed ID: 30606201
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.
Viehman JA; Nguyen MH; Doi Y
Drugs; 2014 Aug; 74(12):1315-33. PubMed ID: 25091170
[TBL] [Abstract][Full Text] [Related]
11. Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
Gontijo AVL; Pereira SL; de Lacerda Bonfante H
Curr Microbiol; 2021 Dec; 79(1):13. PubMed ID: 34905109
[TBL] [Abstract][Full Text] [Related]
12. Acinetobacter baumannii: biology and drug resistance - role of carbapenemases.
Nowak P; Paluchowska P
Folia Histochem Cytobiol; 2016; 54(2):61-74. PubMed ID: 27270503
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
